Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opzelura Experience Study
NCT07661979Phase 4Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 4 trial of ruxolitinib cream in atopic dermatitis (AD), sponsored by Wake Forest University Health Sciences. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
ruxolitinib cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07661979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07661979.